WILMINGTON, Del., March 12, 2025 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals (NRXP)", the "Company"), a clinical-stage biopharmaceutical company, today announced ...
WILMINGTON, Del., March 17, 2025 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced its financial ...
NRX-100 (IV, preservative-free ketamine)According to the CDC, more than 13 million adults contemplate suicide each year; NRX-100 – IV ketamine for Suicidal Depression - can help address this national ...
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Fourth Quarter and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results